Physician profile
Carla L Wright
NPI 1861539421
$3,925.25
in general payments reported to CMS, 2019-2025
24 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2020: $347 · 2021: $757 · 2022: $520 · 2023: $635 · 2024: $241 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $537.19 | 2019-2022 | |
| Novo Nordisk INC | $514.78 | 2020-2023 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $466.70 | 2019-2022 | |
| Allergan, INC. | $361.07 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $343.53 | 2019-2022 | |
| Abbvie INC. | $250.18 | 2022-2024 | Dalvance |
| Horizon Therapeutics Plc | $249.75 | 2021-2023 | Krystexxa |
| Glaxosmithkline, LLC. | $164.55 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $162.68 | 2021-2023 | |
| Pfizer INC. | $157.78 | 2019-2021 | |
| Genentech USA, INC. | $131.17 | 2019 | |
| Paratek Pharmaceuticals, INC. | $125.00 | 2024 | Nuzyra |
| Medtronic, INC. | $121.70 | 2025 | Intellis Adaptivestim |
| Sanofi Pasteur INC. | $94.78 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.08 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $40.45 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $38.68 | 2019 | |
| Exact Sciences Corporation | $28.11 | 2023 | Cologuard Collection Kit |
| Grt US Holding, INC. | $15.34 | 2022 | |
| Agile Therapeutics, INC. | $15.32 | 2021 | |
| Intercept Pharmaceuticals, INC. | $14.19 | 2020 | |
| Shire North American Group INC | $14.01 | 2019 | |
| Lilly USA, LLC | $12.02 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $3.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.